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Abstract
Two-dimensional molybdenum disulfide (MoS2) has distinct optical and electronic properties 
compared to aggregated MoS2, enabling wide use of these materials for electronic and biomedical 
applications. However, the hazard potential of MoS2 has not been studied extensively. Here, we 
present a comprehensive analysis of the pulmonary hazard potential of three aqueous suspended 
forms of MoS2: aggregated MoS2 (Agg-MoS2), MoS2 exfoliated by lithiation (Lit-MoS2) and 
MoS2 dispersed by Pluronic F87 (PF87-MoS2). No cytotoxicity was detected in THP-1 and 
BEAS-2B cell lines. However, Agg-MoS2 induced strong pro-inflammatory and pro-fibrogenic 
responses in vitro. In contrast, Lit- and PF87-MoS2 had little or no effect. In an acute toxicity 
study in mice, Agg-MoS2 induced acute lung inflammation, while Lit-MoS2 and PF87-MoS2 had 
little or no effect. In a sub-chronic study, there was no evidence of pulmonary fibrosis in response 
to all forms of MoS2. These data suggest that exfoliation attenuates the toxicity of Agg-MoS2, 
which is an important consideration towards the safety evaluation and use of nanoscale MoS2 
materials for industrial and biological applications.
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1. Introduction
Molybdenum disulfide (MoS2), a typical transition metal dichalcogenide, is a flat tri-layer 
material composed of a layer of molybdenum bonded on either side to layers of sulfur.[1] It 
has generated significant attention as a post-graphene two-dimensional material due to its 
extraordinary electronic, optical, and physical properties that lend themselves to a wide 
variety of applications including catalysis, electronics, and therapeutics.[1, 2] Among 
different production methods of nanoscale two-dimensional MoS2 (2D-MoS2), solution-
based processing promises exceptional scalability and low cost, and thus represents the most 
probable path for incidental exposure including pulmonary exposure.[3, 4] As solution-based 
nanoscale MoS2 is poised to enter the market, it is essential to identify its toxic potential and 
develop safe methods for handling nanoscale MoS2.
MoS2 is currently used in spray and automobile lubrication products in the market place in 
its bulk form, with the potential to lead to aerosolized inhalation exposure in humans. In 
fact, most reports on MoS2 are for the bulk form, which demonstrated good in vivo 
biocompatibility by the U.S. Public Health Service.[5] No fatalities or adverse health effects 
were observed in rats and guinea pigs following inhalation exposure to the bulk materials.[5] 
The low toxicity is attributed to MoS2 being chemically inert and insoluble in body fluids. 
However, no comprehensive hazard assessment work has been conducted for nanoscale 
MoS2 materials to date. In order to assess the potential toxicity of solution-based nanoscale 
MoS2 materials, we established a representative test library that includes three aqueous 
forms of nanoscale MoS2: aggregated MoS2 (Agg-MoS2) and two dispersed types of 
nanoscale MoS2: one that is chemically exfoliated by lithium ion intercalation (Lit-MoS2), 
and another that is dispersed using ultrasonication in the presence of a biocompatible block 
copolymer, Pluronic F87 (PF87-MoS2). These three samples are representative of the 
possible aqueous nanoscale dispersions of MoS2 that may enter the market for the 
aforementioned applications, spanning chemically and ultrasonically exfoliated, as well as 
non-surfactant and surfactant stabilization, respectively.
Against this background, we set out to determine whether nanoscale MoS2 materials pose a 
biological hazard in vitro and in vivo. We demonstrate that while Agg-MoS2 is capable of 
inducing strong pro-inflammatory and pro-fibrogenic responses in vitro, Lit- and PF87-
MoS2 had little or no effects. In an acute oropharyngeal exposure study in mice, Agg-MoS2 
induced acute lung inflammation, while Lit- and PF87-MoS2 had decreased inflammation or 
no effects. In a sub-chronic study, all forms of MoS2 did not induce lung fibrosis. Our data 
suggest that the exfoliation process attenuates the hazard potential of nanoscale 2D-MoS2 
compared to Agg-MoS2. Overall, these results suggest strategies for the safe use of 
nanoscale 2D-MoS2 materials in industrial and biomedical applications.
2. Results and Discussion
2.1. Preparation and Characterization of Molybdenum Disulfide (MoS2)
All MoS2 samples were prepared from an original batch of the bulk material. Pluronic F87 
dispersed MoS2 (PF87-MoS2) was prepared by ultrasonication of MoS2 powder in a solution 
of PF87 in DI water. Pluronic® is a non-ionic triblock copolymer composed of two 
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hydrophilic poly (ethylene oxide) (PEO) end pieces and a central hydrophobic poly 
(propylene oxide) (PPO) segment.[6] Previous studies have demonstrated that several types 
of Pluronic can effectively disperse carbon nanotubes (CNTs) and graphene due to the 
amphiphilic nature of these polymers, providing electrosteric hindrance of the coated 
surface.[7-9] Because Pluronic colloid interactions are subject to the particle dimensions and 
the length of the polymer chains, PF87 was chosen for its enhanced ability to disperse MoS2 
at high concentrations.[10] Aggregated MoS2 was prepared by flocculation of PF87-MoS2. 
Since lithium intercalation is the most widely used method for chemical exfoliation of bulk 
MoS2 into 2D-MoS2, lithiated MoS2 (Lit-MoS2) was synthesized by exposing the bulk 
powder to a n-butyllithium solution, followed by bath sonication, purification and 
concentration procedures.[11]
Agg-, Lit- and PF87-MoS2 were comprehensively characterized. While Agg-MoS2 is 
beyond the size range for AFM measurements, scanning electron microscopy (SEM) 
analysis shows that these particles span several microns in width and thickness (Figure 1A). 
AFM assessment of PF87-MoS2 show that these particles have a mean square root surface 
area of 27.6 ± 15.6 nm and an average height of 5.2 ± 1.1 nm (Figure 1B, E and F). Similar 
measurements show that the Lit-MoS2 particles are larger than PF87-MoS2, which have a 
mean square root surface area of 187.5 ± 126.9 nm and a mean height of 3.9 ± 0.6 nm 
(Figure 1C, E and F). The hydrodynamic sizes of Agg- and Lit-MoS2 suspended in RPMI 
1640 are smaller than BEGM due to the presence of fetal bovine serum (FBS). PF87-MoS2 
is better dispersed than Agg- and Lit-MoS2 in both media (Table 1). The zeta potentials of 
the three material types were in the range of −4.3 to −8.8 mV in cell culture media, and 
−12.9 to −34.3 mV in water (Table 1).
2.2. 2D-MoS2 exerts less pro-inflammatory effects than Agg-MoS2 in vitro
We determined the pro-inflammatory responses of MoS2 using THP-1 and BEAS-2B cell 
lines. The myeloid cell line, THP-1, was chosen because it can be differentiated into a 
lineage with macrophage-like properties,[12] while BEAS-2B cells are derived from human 
bronchial epithelial cells.[13] These cell types are representative of the cell types that provide 
the first line of defense at the portal of entry into the lung. Use of these cells demonstrated in 
an MTS assay that none of the MoS2 form variations had an effect on cell viability (Figure 
2A, B). It is noteworthy that literature show that some types of nanomaterials, including 
MoS2, have interference with MTT reagent at high dose level (> 100 μg/mL) when 
measuring the absorbance at 490 nm.[14-17] Accordingly, we conducted an abiotic 
experiment to measure the absorbance of the mixture of MoS2 and MTS reagent at 490 nm. 
We found that there was no interferences between MoS2 and MTS reagent within the dose 
range (0 to 50 μg/mL) we in this work (data not shown). Additionally, the MTS results were 
confirmed in a different viability assay, i.e. a luminescence-based cellular assay that 
determines ATP content as a measure of viability (Figure S1A, B). When testing pro-
inflammatory cellular effects, however, we observed that while Agg-MoS2 induced 
significant increases in IL-8, TNF-α and IL-1β production, there were significantly less 
effects of Lit- or PF87-MoS2 on cytokine and chemokine production in BEAS-2B and 
THP-1 cells (Figure 3B and C). These cytokines and chemokines play important roles in 
lung inflammation in response to inhaled foreign materials. IL-8, known as a neutrophil 
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chemotactic factor, can induce neutrophil chemotaxis and migration toward sites of particle 
deposition and inflammation.[18, 19] TNF-α is a member of a group of macrophage-derived 
cytokines that also play a role in acute inflammation.[20] IL-1β is an important mediator of 
acute and sub-chronic inflammatory responses, which can also lead to fibrogenic effects in 
response to particulate substances and fibers in the lung.[12, 21] Agg-MoS2 also induced 
increased TGF-β1 and PDGF-AA production in a co-culture of THP-1 with BEAS-2B cells 
(Figure S1C and D). These growth factors could be significant from the perspective of pro-
fibrogenic pulmonary responses since synergy with IL-1β during epithelial-mesenchymal 
transition in the lung in response to carbon nanotubes, graphene and asbestos fibers plays a 
key role in pulmonary fibrosis.[21-23] Whether growth factor production will result in 
pulmonary fibrosis is dependent on the magnitude and duration of the pulmonary response, 
which is shaped by the dose, lung burden, removal and persistence of the material.[21, 23, 24]
Bioavailability plays an important role in engineered nanomaterials (ENM)-induced cellular 
responsiveness.[25-28] Under experimental conditions, the colloidal stability of the aqueous 
suspended materials can affect the sedimentation and contact of the materials with cells on 
the surface of the tissue culture dish.[29] Assessment of the suspension stability index of the 
various MoS2 materials in BEGM and RPMI 1640 demonstrated that, while PF87-MoS2 
showed excellent stability in both culture media, Agg-MoS2 was the least stable (Figure 
S2A and B), leading to rapid settling at the bottom of the dishes. Since this could lead to 
enhanced bioavailability, confocal Raman spectroscopy was used to assess MoS2 uptake in 
THP-1 cells; MoS2 yields characteristic peaks at 382 and 406 nm (Figure S3). While Agg-
MoS2 was associated with a robust Raman signature, less pronounced peaks were observed 
for Lit- and PF87-MoS2 (Figure S3). Since the Raman signal is not quantitative, we also 
used ICP-OES to assess cellular content. This measurement demonstrated that Agg-MoS2 
was present in higher abundance, compared to other materials (Figure 1C and D), with 
PF87-MoS2 showing the least cellular association. Since these data show good correlation to 
the lesser pro-inflammatory effects of PF87-MoS2, it would appear that bioavailability of 
the materials could indeed determine the effects on cytokine and chemokine production.
2.3. 2D-MoS2 exerted less acute pro-inflammatory effects in the lung than Agg-MoS2
MoS2 materials are currently used in spray and automobile lubrication products in the 
market place, with the potential to lead to aerosolized exposure upon inhalation in humans. 
To determine if MoS2 poses pulmonary hazard potential, we used oropharyngeal aspiration 
to compare our characterized MoS2 materials in C57Bl/6 mice. Due to the absence of MoS2 
exposure data in humans, we used, for comparison, exposure data for MWCNTs in a 
production laboratory, where the airborne concentration of the tubes can be as high as 400 
μg/m3. [30] Assuming a ventilation rate of 20 L/min in healthy human subjects [31] and a 
particle deposition fraction of 30 %, the estimated exposure (8 h/day, 5 d/week for 16 
weeks) of an adult could reach 92.16 mg. Using a human lung alveolar surface area of 102 
m2,[32] this is equivalent to a deposition level of 903.53 μg/m2 in the lung (Table S1). This 
equals a dose of 1.81 mg/kg in a 25 g mouse with an alveolar epithelial surface area of 0.05 
m2.[32] Accordingly, we decided on a 2 mg/kg dose for bolus instillation studies in mice. 
The positive control included oropharyngeal delivery of 5 mg/kg of Min-U-Sil (α-quartz), a 
highly inflammogenic material associated with both acute and sub-chronic lung toxicity. 
Wang et al. Page 4
Small. Author manuscript; available in PMC 2016 October 01.
Author M
anuscript
Author M
anuscript
Author M
anuscript
Author M
anuscript
Forty hours after oropharyngeal aspiration, Min-U-Sil could be seen to induce significant 
increases in LIX (LPS-induced CXC chemokine), MCP-1 (monocyte chemoattractant 
protein-1), IL-6 levels and neutrophil counts in the bronchoalveolar lavage fluid (BALF), 
along with mild inflammatory changes in the lung (Figure 4 A-E). While Agg-MoS2 
induced robust LIX (Figure 4A), MCP-1 (Figure 4B), and IL-6 responses (Figure 4C) along 
with neutrophilic exudation into the BALF (Figure 4D), Lit- and PF87-MoS2 did not trigger 
cytokine or chemokine production in the lung (Figure 4A, B and C). Moreover, the 
exfoliated materials only mounted mild neutrophilic increases in the BALF (Figure 4D). 
Histopathological changes in animal lungs confirmed these differential effects (Figure 4E), 
with Agg-MoS2 inducing focal areas of inflammation around small airways, while Lit- and 
PF87-MoS2 had little or no effect (Figure 4E).
It is helpful for predictive toxicological modeling to be able to reconcile in vitro with in vivo 
dosimetry. We used the lung alveolar epithelium surface area to calculate a surface area dose 
(SAD) in the mouse. An animal exposed to 2 mg/kg MoS2 is equivalent to a SAD of 1 
mg/m2 in a 25 g mouse with an alveolar epithelium surface area of 0.05 m2.[32] Assuming 
that the MoS2 dose is homogeneously distributed in the tissue culture dish and that the 
thickness of a cell layer is ~ 15 μm, the in vitro exposure dose would be ~ 66 μg/mL. Thus, 
the in vitro dose range (6.25 - 50 μg/mL) that we chose is comparable to the dose in the 
mouse experiment.
2.4. 2D- as well as Agg-MoS2 failed to induce sub-chronic inflammatory effects in the lungs 
of mice
We also determined the sub-chronic effects of MoS2 in the lung, 21 days post-exposure. 
Examination of the BALF showed that neutrophil influx had largely disappeared at this 
point for all of the MoS2 materials, while quartz still resulted in residual inflammation (not 
shown). Moreover, Min-U-Sil aspiration was associated with increased levels of TGF-β1 
(Figure 5A) and PDGF-AA (Figure 5B) in the BALF, confirming its pro-fibrogenic 
potential. However, while Agg-MoS2 and Lit-MoS2 induced significant increases of the 
TGF-β1 in the BALF, none of the MoS2 materials had an effect on PDGF-AA production 
(Figure 5A and B). While Min-U-Sil resulted in increased collagen production at 21 days, as 
determined by a Sircol assay (Figure 5C) as well as Masson’s trichrome staining (Figure 
5D), none of the MoS2 materials resulted in increased collagen production or interstitial 
collagen deposition in the lungs of exposed animals (Figure 5D).
All considered, there is good agreement between the in vivo and in vitro hazard ranking of 
MoS2 in spite of differences in the cellular handling in the lung versus tissue culture 
conditions. While sedimentation of Agg-MoS2 is likely a major determinant for cellular 
uptake and bioavailability in the tissue culture dish (Figure 2C and D), its uptake by 
epithelial cells and macrophages in the lung takes place at deposition sites where the 
aqueous carrier is absorbed or removed by the ciliary escalator. Thus, the role of 
sedimentation at deposition sites in the lung is likely to be limited, with the state of 
dispersion determining how widespread the dissemination of the particles will be. It is 
interesting, therefore, that ICP-OES analysis demonstrated less variation in the lung content 
of the various MoS2 materials 40 h after initial aspiration (Figure 6A). While slightly less 
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for Lit-MoS2 and PF87-MoS2 than Agg-MoS2, the lung content was not statistically 
significant among the materials and therefore quite different from the variation seen in the 
cellular studies (Figure 2C and D). This was confirmed by Raman confocal microscopy, 
which showed prominent MoS2 peaks for all MoS2 materials in alveolar macrophages 
(Figure S4A). Thus, the lung burden and acute in vivo bioavailability do not explain the 
failure of the exfoliated materials to induce acute lung inflammation. A similar trend was 
seen for ICP-OES analysis at 21 d, at which point the lung burden was considerably reduced 
(Figure 6B). While there was less retention of PF87-MoS2, the lung contents of Agg- and 
PF87-MoS2 were similar. This suggests that the absent or reduced inflammatory effects of 
the exfoliated materials in the lung has less to do with the total dose than the decreased 
inflammogenic potential of Lit- and PF87-MoS2 in the lung. This could be a function of the 
surface reactivity of the materials and/or their state of dispersal. In addition to improving 
material dispersal, Pluronic coating of MWCNTs, SWCNTs, and graphene has been shown 
to reduce surface reactivity at the cellular or pulmonary interface through steric 
hindrance.[7-9] Steric hindrance results from binding of the hydrophobic midblock region of 
the polymer to the hydrophobic surface of these materials, leaving the hydrophilic PEO end-
blocks to stand away from the surface, thereby providing a protective coating.[9] We propose 
that PF87 plays a similar role on the surface of MoS2, which prevents the surface from 
triggering pro-inflammatory cellular responses. Lithiation could also reduce surface 
reactivity, bioavailability or may act to increase the clearance of MoS2 in the lung. 
Altogether, these data show that 2D-MoS2 nanomaterials are safer than Agg-MoS2.
Data about the safety of 2D-MoS2 materials are limited. Recently, Pumera et al. reported 
that under in vitro conditions, MoS2 nanosheets failed to affect the viability of A549 cells 
when compared to other transition-metal dichalcogenides (TMDs), including WSe2.[16] 
However, the same group also demonstrated that MoS2 nanosheets, obtained through the use 
of n-butyllithium (n-Bu-Li) or tert-butyllithium (t-Bu-Li) as exfoliating agents, can be 
cytotoxic at high dose range (200 to 400 μg/mL).[16, 17] While it is difficult to interpret this 
data without more comprehensive information about the physicochemical characterization of 
these materials, it is possible that material aggregation at high dose or the presence of 
residual lithium ions could be involved in the toxicity outcome. Moreover, the use of 
cytotoxicity as the sole criterion of material hazard may not reveal sublethal effects, such as 
the pro-inflammatory responses in cells and the lung, as we show in this study. Also the high 
dose levels used by Pumera et al. may not be representative of real life exposure conditions. 
We believe our study provides more realistic exposure conditions, ultimately leading to the 
conclusion that 2D-MoS2 nanomaterials are relatively safe.
3. Conclusion
In summary, we addressed the lack of hazard assessment for nanoscale MoS2 by performing 
comprehensive in vitro and in vivo toxicological analysis for exfoliated vs. aggregated MoS2 
materials. Our results demonstrate that 2D-MoS2, including Lit- and PF87-MoS2, elicit 
significantly reduced pro-inflammatory effects compared to Agg-MoS2 at cellular and lung 
levels. In addition, all MoS2 formulations did not induce sub-chronic effects in the lung. The 
reduced hazard of 2D-MoS2 materials is correlated to improved dispersion and surface 
coating, which play important roles in determining the bioavailability and surface reactivity 
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of the exfoliated materials. These data suggest that 2D-MoS2 materials are safer than Agg-
MoS2, which may promote the safe use of 2D-MoS2 for industrial and biomedical 
applications.
4. Experimental Section
4.1. Preparation of Nanoparticle suspensions
The molybdenum disulfide (MoS2) dispersions were prepared as follows: For lithiated MoS2 
(Lit-MoS2), lithium ion intercalation was achieved by exposing 300 mg of MoS2 powder 
(Sigma Aldrich) to 3 mL of 1.6 M butyllithium solution in hexane while gently stirring for 
48 h in an Argon-filled glovebox. The slurry was subsequently transferred to a filter and 
rinsed with 60 mL hexane. Upon removal from the glovebox, the powder was immersed in 
500 mL DI water and bath sonicated immediately to prevent de-intercalation and promote 
full exfoliation of the MoS2. The exfoliated solution was briefly centrifuged to remove non-
exfoliated MoS2 and then dialyzed for 7 days to remove excess lithium and hexane. Finally, 
the solution was removed from dialysis and concentrated using vacuum filtration. Pluronic 
F87 dispersed MoS2 (PF87-MoS2) was prepared by immersing 300 mg of MoS2 powder in 8 
mL 2 % w/v PF87 (BASF) solution in DI water, and then ultrasonicated for 1 h at an 
amplitude of approximately 16 Watts. The slurry was centrifuged to remove any non-
exfoliated material and aggregates by retaining only the top 80 % of the supernatant. The 
solution was dialyzed for three days and concentrated using vacuum evaporation. The 
aggregated MoS2 (Agg-MoS2) was prepared from the PF87 dispersion by inducing 
flocculation through the addition of four parts isopropyl alcohol to one part PF87-MoS2. The 
aggregates were filtered from the solution and rinsed thoroughly with DI water, and then 
resuspended by bath sonication in DI water. The concentrations of the MoS2 solutions were 
measured using ICP-MS as described previously.[33] Briefly, MoS2 solutions were digested 
overnight at 65 °C in nitric acid and subsequently diluted with water and internal standard. 
Using the ICP-MS measurements, concentration was inferred stoichiometrically.
4.2. Cell culture and co-incubation with Molybdenum Disulfide
BEAS-2B and THP-1 cells were obtained from ATCC (Manassas, VA). 1×104 BEAS-2B 
cells were cultured in 0.1 mL BEGM in 96-well plates at 37 °C. THP-1 cells were pretreated 
with 1 μg/mL phorbol 12-myristate acetate (PMA) overnight and primed with 10 ng/mL 
lipopolysaccharide (LPS) to provide transcriptional activation of the IL-1β precursor.[12] 
Both types of cells were subsequently cultured in 96-well plates (Costar, Corning, NY, 
USA) at 37 °C for 24 h. MoS2 suspensions were added to these cultures at 6.25- 50 μg/mL. 
After 24 h of culture, the supernatants were collected for the measurement of IL-8, TNF-α, 
and IL-1β levels (BD Biosciences, San Diego, CA), using ELISA kits. Cytokine levels were 
expressed as pg/mL.
4.3. Cytotoxicity Assessment
Cytotoxicity was determined by an MTS assay, which was carried out with CellTiter 96 
Aqueous (Promega Corp.) kit. 1 × 104 BEAS-2B or 3× 104 THP-1 cells in 100 μL of culture 
medium were plated in each well of a 96 multiwell plate (Costar, Corning, NY) for 
overnight growth. The medium was removed, and cells were treated for 24 h with 100 μL of 
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6.25-50 μg/mL MoS2 suspensions. After the treatment, the cell culture medium was 
removed and followed by washing of the plates three times with PBS. Each well received 
120 μL of culture medium containing 16.7 % of MTS stock solution for 1 h at 37 °C in a 
humidified 5 % CO2 incubator. The plate was centrifuged at 2000 g for 10 min in NI 
Eppendorf 5430 with a microplate rotor to spin down the cell debris. An 85 μL amount of 
the supernatant was removed from each well and transferred into a new 96 multiwell plate. 
The absorbance of formazan was read at 490 nm on a SpectraMax M5 microplate reader 
(Molecular Devices Corp., Sunnyvale, CA, USA).
4.4. Oropharyngeal aspiration studies in mice
Eight-week-old male C57Bl/6 mice received oropharyngeal aspiration of Agg-MoS2, Lit- or 
PF87-MoS2 materials, as previously described.[12] Briefly, 2 mg/kg of each type of MoS2 
suspension was instilled at the back of the tongue in 50 μL water in anesthetized animals. 
Control animals received the same volume of water. Crystalline silica (Min-U-Sil) was used 
as a positive control at 5 mg/kg. The mice were sacrificed after 40 h and 21 days, 
respectively, to assess acute and sub-chronic effects. BALF and lung tissue were collected 
for measurement of LIX, MCP-1, IL-6, TGF-β1, and PDGF-AA levels and performance of 
Hematoxylin and Eosin (H&E) or Masson’s trichrome staining. The detailed methods 
appear in the Supporting Information.
4.5. Statistical Analysis
Mean and standard deviation (SD) were calculated for each parameter. Results were 
expressed as mean ± SD of multiple determinations. Comparisons of each group were 
evaluated by two-sided Student’s t tests. A statistically significant difference was assumed 
when p was <0.05.
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Figure 1. 
Characterization of Agg-, Lit- and PF87-MoS2. (A) Scanning electron micrograph of Agg-
MoS2. (B, C) Representative atomic force microscopy (AFM) images of PF87-MoS2 and 
Lit-MoS2. (D) Optical absorbance spectra of PF87-MoS2 and Lit-MoS2. (E, F) AFM 
histograms of flake thickness and lateral flake sizes in the exfoliated materials.
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Figure 2. 
Cytotoxicity and cellular Mo content in BEAS-2B and THP-1 cells exposed to MoS2 
materials. Assessment of cytotoxicity of MoS2 on BEAS-2B (A) and THP-1 cells (B). Both 
cell types were grown in 96-well plates, followed by exposure to 6.25, 12.5, 25 and 50 
μg/mL of each of the Agg-, Lit- and PF87-MoS2 suspensions for 24 h. The media were 
subsequently washed with PBS and replaced with 120 μL aliquots of the MTS working 
solution. After incubation for an hour, the plates were centrifuged to collect the 
supernatants, and their absorbance read at 490 nm in a microplate reader (SpectroMax M5e, 
Molecular Devices, Sunnyvale, CA). All the MTS values were normalized according to the 
non-treated control, which was regarded as representing 100 % cell viability. (B) Total 
cellular Mo content in BEAS-2B (C) and THP-1 (D) cells as determined by ICP-OES. Both 
cell types were exposed to 50 μg/mL MoS2 for 24 h, following which the cells were 
recovered, sonicated and used for acid digestion. The concentration in each sample was 
expressed as μg Mo per mg of cellular protein.
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Figure 3. 
In vitro pro-inflammatory effects of Agg-, Lit- and PF87-MoS2. The supernatants from the 
studies shown in Figure 2 were collected to determine IL-8 (A), TNF-α (B) and IL-1β (C) 
levels by ELISA. Monosodium urate (MSU) crystals at 100 μg/mL was used as a positive 
control to measure IL-1β release in response to assembly of the NRLP3 inflammasome. *p < 
0.05 compared to control.
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Figure 4. 
Acute pulmonary effects of Agg-, Lit- and PF87-MoS2 in mice. Anesthetized C57BL/6 mice 
were exposed to dispersed MoS2 materials, delivered by one-time oropharyngeal aspiration 
of a bolus dose of 2.0 mg/kg. There were 6 animals per group. Animals were euthanized 
after 40 h, and BALF was collected to determine LIX (A), MCP-1 (B), and IL-6 (C) levels 
as well as measuring neutrophil cell counts (D) l. Quartz (QTZ) was used as a positive 
control, at 5.0 mg/kg. *p < 0.05 compared to control. (E) Representative H&E-stained 
histological images (100 ×) of the lungs of MoS2 treated mice.
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Figure 5. 
Assessment of the possible fibrotic effects of MoS2 materials 21 days after oropharyngeal 
installation. The experiment, described in Figure 4, was repeated with the exception that 
animal sacrifice was performed 21 days after oropharyngeal inspiration of a similar particle 
dose. There were 6 animals in each group. After the animals were euthanized, BALF was 
collected to determine TGF-β1 (A) and PDGF-AA (B) levels. (C) Total collagen content of 
the lung tissue was determined using the Sircol collagen kit (Biocolor Ltd., Carrickfergus, 
U.K.). *p < 0.05 compared with control. (D) Collagen deposition in the lung as determined 
by Masson’s trichrome staining. Lung tissue was embedded, sectioned, stained with the 
Masson’s trichrome and observed at 100 × magnification. Blue staining represents collagen 
deposition in the lung. Animals exposed to Quartz (QTZ) served as positive control.
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Figure 6. 
Comparison of the Mo content in lung, 40 h (A) and 21 d (B) post-exposure as determined 
by ICP-OES. The lung tissues from the experiments in Figure 4 and 5 were collected and 
digested by concentrated nitric acid and hydrogen peroxide. The total Mo content in each 
lung sample was determined by ICP-OES.
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Table 1
Characterization of MoS2 materials in cell culture media
In H2O In cRPMI1640 In BEGM
ζ [mV] dH [nm] ζ [mV] dH [nm] ζ [mV] dH [nm]
Agg-MoS2 −23.6 ± 0.4 1334.8±47.8 −5.4±1.9 540.8±18.1 −8.8±1.6 1144.7±152.5
Lit-MoS2 −34.3 ± 0.1 506.3±11.8 −7.7±3.0 585.6±17.3 −4.3±0.5 746.4±100.3
PF87-MoS2 −12.9 ± 1.2 72±0.8 −7.8±1.3 80.1±0.8 −8.5±1.4 78.4±0.7
The zeta potential was measured using a ZetaSizer Nano-ZS (Malvern Instruments, Worcestershire WR, UK). The hydrodynamic diameters in 
H2O, RPMI 1640 and BEGM were determined using high throughput dynamic light scattering (HT-DLS, Dynapro Plate Reader, Wyatt 
Technology).
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